While cognitive impairments are prevalent in first-episode psychosis, the course of these deficits is not fully understood. Most deficits appear to remain stable, however there is uncertainty regarding the trajectory of specific cognitive domains after illness onset. This study investigates the longitudinal course of cognitive deficits four years after a first-episode of psychosis and the relationship of performance with clinical course and response to treatment.
Introduction
Deficits in many areas of cognition are prevalent in individuals who experience a first-episode of psychosis (FEP), many of which are also present in the prodromal phase of psychosis. Visual memory, verbal learning, attention, working memory, executive function and social cognition are common cognitive domains impaired in FEP compared to the performance of healthy controls (Bora et al., 2014 , Aas et al., 2014 , Üçok et al., 2013 . It is important to elucidate the trajectory of cognitive dysfunction following an initial psychotic episode, and any clinical or biological determinants of such progression, which can only be established by longitudinal studies of cognitive function.
In general, it has been shown that the majority of cognitive deficits remain stable following an initial psychotic episode (Bozikas and Andreou, 2011; Bora and Murray, 2013) , although there is variability throughout the literature. For example, verbal learning has variously been reported to either remain stable over 3 years , to deteriorate over 10 years and 13 years (Bozikas and Andreou, 2011, Øie et al., 2010) ; or to improve over 6 months and 2 years (Jahshan et al., 2010; Barder et al., 2013) . A table of recent longitudinal studies, consisting of studies additional to the meta-analysis by Bora and Murray (2013) is provided in Table 1 .
The heterogeneity of results in the literature may partly relate to the lack of a congruent set of cognitive tests administered to assess cognitive performance, which also restricts comparison of findings across studies. Measuring performance of a cognitive construct using alternative tests can result in incongruent findings . The current study aimed to address this issue by implementing the MATRICS Consensus Cognitive Battery (MCCB), which was developed by the National Institute of Mental Health's (NIMH) Measurement and Treatment Research to Improve Cognition in Schizophrenia (MATRICS). The MCCB identified seven separable dysfunctional cognitive factors in the disorder, two of which (attention and working memory) are concurrent with the cognitive constructs of the NIMH Research Domain Criteria (RDoC) (Cuthbert and Insel, 2010) . The MCCB demonstrates excellent test-retest reliability and minimal practice effects (Roseberry and Kristian Hill, 2014, Nuechterlein et al., 2008) . Of the few FEP longitudinal studies that implemented the MCCB, Juuhl-Langseth et al. (2014) found that most neurocognitive deficits were relatively stable over two years apart from the course of processing speed.
The current study additionally sought to investigate the relationship between cognitive deficits in psychosis and other clinical and quality of life measures as the nature of these relationships remain inconclusive. In terms of clinical symptomatology, cognitive deficits are proposed to be more closely associated with negative and disorganised aspects of psychosis compared with positive symptoms (Bora and Murray, 2013; Dominguez et al., 2009) . Attention, psychomotor speed and verbal learning in particular have been found to correlate with negative symptoms in schizophrenia (August et al., 2012; Bora and Murray, 2013; O'Gráda et al., 2009) , while disorganised symptoms were related to lower verbal and visual learning, processing speed and social cognition (August et al., 2012; Flaum et al., 2000) . Whether or not cognitive performance differs significantly between subtypes of psychosis, such as affective and non-affective subtypes, has not been determined conclusively. Some evidence has suggested verbal learning performance to differ between individuals with schizophrenia from those with affective disorders (Fitzgerald et al., 2004) but this is not a consistent finding (Bora et al., 2009 ). Finally, longitudinal associations between cognitive deficits and quality of life outcome in schizophrenia have been supported by a review of 18 studies (Green et al., 2004) , albeit with considerable variability (Tolman et al., 2010) .
This study aims to characterise the longitudinal course of cognitive deficits four years after a first episode of psychosis using the standardised MCCB, to determine the nature and degree of variation in cognitive performance and critically, to examine the relationship of performance with clinical course and response to treatment. 
Tables

2.Methods
Participants
Initially, 36 individuals who experienced a first episode of psychosis (FEP) and 59 healthy controls (HC) participated in cognitive and clinical assessments. Individuals with a diagnosis of psychosis were from the mental health services at University Hospital Galway and the surrounding mental health services in the west of Ireland. All subjects were aged between 18-49 years at baseline ( Table 2) . The recruitment and clinical assessment of these individuals is described previously (McFarland et al., 2013; Scanlon et al., 2014) . Exclusion criteria for both groups were as follows: a history of neurological disorders (including epilepsy), comorbid substance or alcohol abuse in the last year, a history of head injury resulting in loss of consciousness for over 5 minutes, a history of oral steroid use in the previous three months, loss of weight in excess of 12% of the original body weight in the previous year and a history of viral infection in previous 1 month. Individuals in the control group were also excluded if there was a personal or family history of psychotic or affective disorder. Written informed consent was obtained from all participants. The study was approved by the research Ethics Committees of the National University of Ireland Galway and Galway University Hospitals. At follow-up, on average four years later (4.3±0.9 years), 23 FEP and 21 HC subjects were successfully re-recruited. Two individuals from the original cohort were un-contactable, 1 individual was unwell, 8 individuals declined the invitation to participate and 2 had relocated to another country. Many individuals in the control group had also relocated making it difficult to re-recruit in that cohort. There was no significant difference in the mean age, gender or baseline diagnosis of individuals from the original cohort who were successfully recruited at follow-up compared to those not recruited.
2.2.Materials
2.2.1.Cognitive Measures
The MCCB was administered to individuals at the time of their first psychotic episode and to a psychiatrically healthy control group. Follow-up testing was completed four years later. A summary of the seven cognitive domains which constitute the MCCB can be found in Table 3 . (Mayer et al., 2003) 
2.2.2.Clinical Assessment
The severity of symptoms in the FEP group were clinically assessed by a trained psychiatrist at both time points using the Positive and Negative Syndrome Scale (PANSS) (Kay and Qpjer, 1982) and the Structured Clinical Interview for DSM-IV Research Version (American Psychiatric Association, 2000). The Quality of Life Scale (QLS) was administered (Heinrichs et al., 1984) at follow-up. Total antipsychotic medication taken was recorded and converted to chlorpromazine (CPZ) equivalents (Lehman and Steinwachs, 1998; Woods, 2003) .
To assess whether affective and non-affective subtypes present differentially, diagnoses at follow-up were categorised into two groups. Schizophrenia (n=6), schizophreniform disorder (n=1), schizoaffective disorder (n=3), psychotic disorder not otherwise specified (4) and delusional disorder (n=1) were defined as non-affective types of psychoses whereas bipolar I disorder (n=6) and major depressive disorder, recurrent (n=2) defined as affective types of psychoses (Table 4 ). 
2.3.Statistics
Raw scores of the cognitive tests were age and gender corrected using the MCCB computerised program, and converted to T-scores, which were then used in all subsequent statistical analyses. Normative data were obtained from administering the battery to 300 individuals across five sites in the U.S. stratified into three age ranges and accounting for gender and education. All statistics were conducted using IBM SPSS (v.21).
Shapiro-Wilk tests were used to test for normal distribution of each cognitive variable. Most cognitive variables at onset of psychosis were normally distributed (W=0.94-0.99,p=0.19-0.93) except for attention (W=0.96,p=0.006), visual learning (W=0.94,p<0.001), speed of processing (w=0.97,p=0.04) and the composite cognition score (W=97,p=0.03). All cognitive measures were normally distributed at follow-up (W=0.92-0.98,p=0.08-0.90) apart from the composite cognitive score (W=0.93,p=0.01). ANOVA models were used to compare group differences in cognitive performance at both time points and the Kruskal-Wallis test was used for the non-normally distributed measures. Cognitive change variables (scores at follow-up minus those at baseline of each cognitive test) were tested for normality of distribution. Positive cognitive change values indicated improvement in performance over time; negative values indicated a decrease over time. Most measures did not deviate from a normal distribution (W=0.94-0.98;p=0.11-0.92), with the exception of a measure of working memory, the spatial span test (W=0.94,p=0.02). This test was transformed for normal distribution using square root transformation (W=0.95,p=0.08) to allow covariates to be accounted for in an ANCOVA model. ANCOVA models with each cognitive change variable were analysed with baseline cognitive scores and years of education included as covariates.
When investigating the longitudinal relationship between any cognitive change variables with significant group differences and clinical and quality of life variables, Pearson's correlation analyses (r) and regression models were used. Non-parametric tests such as Spearman's correlation (ρ) were used with non-normally distributed clinical variables.
3.Results
Healthy controls (HC) performed significantly better than individuals experiencing their first episode of psychosis (FEP) on all measures of cognition at baseline and follow-up, the only exception being social cognition scores at follow-up where no group difference was found (Table 5 ). 
† -30%** Note: FEP = first episode psychosis; HC = healthy controls; † median used where non-normal distribution; *** p< 0.001 **p< 0.01 * p < 0.05; % difference = percentage difference of FEP scores relative to HC scores A significant group difference was found between the FEP group and controls on the change in performance over time on a visuomotor test of processing speed, the Trail Making Test and a verbal index of processing speed, the Verbal Fluency test. A significant group difference was also found on the change in verbal learning performance over time (Table 6 ; Figure 1 ). There was no significant group difference in the change in performance on the remaining cognitive metrics ( Table 6) . The results remained similar without covarying for years of education or when the NART (National Adult Reading Test; Nelson et al., 1991) was covaried in place of years of education (Table 6) . Similarly, the magnitude and direction of the findings remained the same when time between testing was additionally covaried for (Table 2) . Results also remained similar when patients on no medication were removed from analysis (n=8), however, there was an additional significant group difference in the composite speed of processing score between this subgroup of FEP individuals taking medication and healthy controls (p=0.02;FEP(m±se)=-4.42±2.4,HC=4.3±1.9). Total chlorpromazine equivalents were not related to those cognitive measures found to have significant group differences (ρ=-0.3--0.1,p=0.1-0.6). Post-hoc analyses were conducted to determine the extent of the influence processing speed and verbal learning had on other cognitive domains. After controlling for processing speed on cognitive scores at illness onset and follow-up (Table 6 ), group differences on cognitive measures decreased substantially and many became non-significant (average % decrease in F value of both time points was 82%). When covarying for verbal learning, group differences on more cognitive tests remained significant although F values moderately decreased (average % decrease in F value was 56%, Table  7 ).
Title- Figure 2 : Capacity for social cognition and reasoning and problem solving at onset of illness to predict the severity of negative symptoms four years later 
Discussion
Longitudinal cognitive performance remained significantly poorer over the four years following a first-episode of psychosis relative to psychiatrically healthy controls (Table 5 ). Two measures of speed of processing, the Trail Making Test and Verbal Fluency test, showed a significant reduction in performance over time, whereas verbal learning displayed a reduced rate of improvement over time, compared to other domains which improved at the same rate as controls (Table 6 ; Figure 1) . These data suggest that the initial psychotic episode may be associated with an additional cost on a persons' cognitive course in these domains over a time spanning at least four years. Secondly, processing speed performance accounted for a considerable amount of variance in the impairments of the other cognitive domains. Finally, poorer clinical outcome, specifically negative symptoms, was associated with greater deficits at illness onset in reasoning and problem solving and social cognition.
The comprehensive deficits in cognitive capacity in individuals with psychosis are consistent with the literature, specifically a reduced improvement in processing speed and verbal learning over time relative to other cognitive domains has previously been reported (Juuhl-Langseth et al., 2014; Rodríguez-Sánchez et al., 2013; Bozikas and Andreou, 2011) , although not uniformly (Leeson et al., 2009) . Stability in the remaining cognitive deficits has also been identified in measures of attention Ayesa-Arriola et al., 2013) social cognition (Horan et al., 2012) working memory de Mello Ayres et al., 2010) reasoning and problem solving (Juuhl-Langseth et al., 2014) and visual learning .
While a broad array of symptoms and deficits in ability contribute to real world disability in schizophrenia, cognition in particular has been identified as a determinant of quality of life. While the current study found no relationship between cognitive deficits in psychosis and quality of life outcome, this may be the result of poor statistical sensitivity or due to the use of the Heinrich's quality of life scale which includes both objective and subjective measures, the latter being associated less with cognition (Tolman et al., 2010) .
As two measures of speed of processing demonstrated reduced performance over time in psychosis, post-hoc analysis additionally examined the processing speed hypothesis, which proposes that slower performance on this measure reduces the ability to process information automatically and effectively and contributes to the deficits in a wide array of cognitive skills (Kelleher et al., 2013; Rodríguez-Sánchez et al., 2007) . In our study, processing speed appeared to play a significant role in the impairment in other cognitive measures such as working memory and attention. Future studies may specifically investigate the impact of cognitive remediation on processing speed for individuals experiencing a first psychotic episode and whether performance on other cognitive domains benefits as a result.
The relationship between cognition and negative symptoms in first episode psychosis and schizophrenia has been well replicated by many groups Murray, 2013, Lam et al., 2014) if not all (Hoff et al., 1999) . When investigating the clinical relevance of our cognitive findings we found poorer cognitive ability, specifically reasoning and problem solving and social cognition at illness onset, to predict greater negative symptom severity four years later. Longitudinally, performance on a variety of cognition domains at illness onset, such as processing speed, IQ, working memory and verbal learning, have been found to relate to the course of negative symptom severity (Leeson et al., 2010; Carlsson et al., 2006; Bora and Murray, 2013; González-Ortega et al., 2013) . Taken together, these data support cognition at illness onset as a potential predictive indicator of illness course; however, there is yet heterogeneity as to which exact cognitive domain which relates to negative symptom severity.
At follow-up, no deficit in social cognition was evident in the individuals who experienced a psychotic episode, potentially due to the possibility of a baseline ceiling effect in the control group.
Despite the absence of a deficit in social cognition at follow-up relative to onset, these data do not definitively support a normalisation in this domain. During and following establishment of the MATRICS battery the sensitivity and specificity of the social cognition domain has repeatedly been questioned, and its relationship to other cognitive domains and other social cognition measures remains uncertain (Pinkham, 2014) . In light of compelling evidence of social cognition deficits among patients with chronic schizophrenia, the failure to observe the expected differences between individuals with psychosis and controls at follow-up leads us to recommend this be explicitly examined in future longitudinal studies.
On nearly all measures, there was a tendency for all participants to score more highly at the second time point, consistent with the existing literature (Bora and Murray, 2013; Rodríguez-Sánchez et al., 2013) . The MCCB has been shown to have minimal practice effects, reducing the likelihood that these improvements reflect practice effects. The young mean age of the sample in this study may have contributed to the improvement in longitudinal cognitive scores, perhaps a reflection of further brain development or education.
A strength of the current study is the well characterised longitudinal sample which is likely to be representative of the first-episode psychosis population. The sample was relatively heterogenous compared to a sample of first episode schizophrenia, although post-hoc analysis did not identify differences between affective and non-affective subtypes which may contribute positively to the generalisability of the findings to the population. Use of the standardised neurocognitive battery also enables compatible comparison of findings in future studies that administer the MCCB. However, as is common in longitudinal studies, a proportion of the sample was lost to follow-up rendering a relatively low sample size which may have reduced statistical power to detect more subtle effects. Additionally, it is possible that the reduced performance in verbal learning and the two measures of processing speed over time may not be directly attributed to the presence of an initial psychotic episode. Other factors that typically co-occur with the onset of psychotic disorders such as social isolation, lack of employment or education may also impact adversely on neurodevelopment and these cognitive skills.
Conclusion
Widespread cognitive deficits persist over four years after an initial psychotic episode. There was a tendency for stable deficit in the majority of cognitive deficits, with the exception of verbal learning and two measures of processing speed, which have a marked poorer trajectory. However, these cognitive impairments in psychosis are malleable as cognitive remediation has improved performance in first episode psychosis and schizophrenia (Østergaard Christensen et al., 2014; Sartory et al., 2005) . Speed of processing performance may moderate deficits in additional cognitive domains in psychosis and negative symptoms four years after a psychotic episode appeared to be partially predicted by performance on reasoning and problem solving and social cognition at illness onset. Targeted early cognitive remediation intervention therefore appears valuable and could potentially impact the course of negative symptoms following a first psychotic episode.
